371 related articles for article (PubMed ID: 10616843)
1. Lovastatin inhibits transforming growth factor-beta1 expression in diabetic rat glomeruli and cultured rat mesangial cells.
Kim SI; Han DC; Lee HB
J Am Soc Nephrol; 2000 Jan; 11(1):80-87. PubMed ID: 10616843
[TBL] [Abstract][Full Text] [Related]
2. Reactive oxygen species mediate high glucose-induced plasminogen activator inhibitor-1 up-regulation in mesangial cells and in diabetic kidney.
Lee EA; Seo JY; Jiang Z; Yu MR; Kwon MK; Ha H; Lee HB
Kidney Int; 2005 May; 67(5):1762-71. PubMed ID: 15840023
[TBL] [Abstract][Full Text] [Related]
3. Roles of connective tissue growth factor and prostanoids in early streptozotocin-induced diabetic rat kidney: the effect of aspirin treatment.
Makino H; Mukoyama M; Sugawara A; Mori K; Suganami T; Yahata K; Fujinaga Y; Yokoi H; Tanaka I; Nakao K
Clin Exp Nephrol; 2003 Mar; 7(1):33-40. PubMed ID: 14586741
[TBL] [Abstract][Full Text] [Related]
4. Characterization of protein kinase C beta isoform activation on the gene expression of transforming growth factor-beta, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats.
Koya D; Jirousek MR; Lin YW; Ishii H; Kuboki K; King GL
J Clin Invest; 1997 Jul; 100(1):115-26. PubMed ID: 9202063
[TBL] [Abstract][Full Text] [Related]
5. Delayed treatment with lithospermate B attenuates experimental diabetic renal injury.
Lee GT; Ha H; Jung M; Li H; Hong SW; Cha BS; Lee HC; Cho YD
J Am Soc Nephrol; 2003 Mar; 14(3):709-20. PubMed ID: 12595507
[TBL] [Abstract][Full Text] [Related]
6. Ethyl pyruvate ameliorates albuminuria and glomerular injury in the animal model of diabetic nephropathy.
Ju KD; Shin EK; Cho EJ; Yoon HB; Kim HS; Kim H; Yang J; Hwang YH; Ahn C; Oh KH
Am J Physiol Renal Physiol; 2012 Mar; 302(5):F606-13. PubMed ID: 22129969
[TBL] [Abstract][Full Text] [Related]
7. Regulation of connective tissue growth factor activity in cultured rat mesangial cells and its expression in experimental diabetic glomerulosclerosis.
Riser BL; Denichilo M; Cortes P; Baker C; Grondin JM; Yee J; Narins RG
J Am Soc Nephrol; 2000 Jan; 11(1):25-38. PubMed ID: 10616837
[TBL] [Abstract][Full Text] [Related]
8. Effect of lovastatin on small GTP binding proteins and on TGF-beta1 and fibronectin expression.
Kim SI; Kim HJ; Han DC; Lee HB
Kidney Int Suppl; 2000 Sep; 77():S88-92. PubMed ID: 10997696
[TBL] [Abstract][Full Text] [Related]
9. GdCl
Li J; Wu B; Hu H; Fang X; Liu Z; Wu S
J Pharmacol Sci; 2020 Feb; 142(2):41-49. PubMed ID: 31831259
[TBL] [Abstract][Full Text] [Related]
10. The Rho-kinase inhibitor, fasudil, attenuates diabetic nephropathy in streptozotocin-induced diabetic rats.
Gojo A; Utsunomiya K; Taniguchi K; Yokota T; Ishizawa S; Kanazawa Y; Kurata H; Tajima N
Eur J Pharmacol; 2007 Jul; 568(1-3):242-7. PubMed ID: 17511984
[TBL] [Abstract][Full Text] [Related]
11. Xiaokeping mixture inhibits diabetic nephropathy in streptozotocin-induced rats through blocking TGF-β1/Smad7 signaling.
Xin C; Xia Z; Jiang C; Lin M; Li G
Drug Des Devel Ther; 2015; 9():6269-74. PubMed ID: 26664048
[TBL] [Abstract][Full Text] [Related]
12. Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC beta inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes.
Koya D; Haneda M; Nakagawa H; Isshiki K; Sato H; Maeda S; Sugimoto T; Yasuda H; Kashiwagi A; Ways DK; King GL; Kikkawa R
FASEB J; 2000 Mar; 14(3):439-47. PubMed ID: 10698958
[TBL] [Abstract][Full Text] [Related]
13. Effects of candesartan, an angiotensin II type 1 receptor blocker, on diabetic nephropathy in KK/Ta mice.
Liao J; Kobayashi M; Kanamuru Y; Nakamura S; Makita Y; Funabiki K; Horikoshi S; Tomino Y
J Nephrol; 2003; 16(6):841-9. PubMed ID: 14736011
[TBL] [Abstract][Full Text] [Related]
14. Expression of transforming growth factor-beta 1 during diabetic renal hypertrophy.
Shankland SJ; Scholey JW; Ly H; Thai K
Kidney Int; 1994 Aug; 46(2):430-42. PubMed ID: 7967355
[TBL] [Abstract][Full Text] [Related]
15. Glomerular expression of thrombospondin-1, transforming growth factor beta and connective tissue growth factor at different stages of diabetic nephropathy and their interdependent roles in mesangial response to diabetic stimuli.
Wahab NA; Schaefer L; Weston BS; Yiannikouris O; Wright A; Babelova A; Schaefer R; Mason RM
Diabetologia; 2005 Dec; 48(12):2650-60. PubMed ID: 16270194
[TBL] [Abstract][Full Text] [Related]
16. Glycosaminoglycan therapy prevents TGF-beta1 overexpression and pathologic changes in renal tissue of long-term diabetic rats.
Ceol M; Gambaro G; Sauer U; Baggio B; Anglani F; Forino M; Facchin S; Bordin L; Weigert C; Nerlich A; Schleicher ED
J Am Soc Nephrol; 2000 Dec; 11(12):2324-2336. PubMed ID: 11095655
[TBL] [Abstract][Full Text] [Related]
17. Effect of enalapril and losartan on the events that precede diabetic nephropathy in rats.
Volpini RA; da Silva CG; Costa RS; Coimbra TM
Diabetes Metab Res Rev; 2003; 19(1):43-51. PubMed ID: 12592643
[TBL] [Abstract][Full Text] [Related]
18. Rescue of mesangial cells from high glucose-induced over-proliferation and extracellular matrix secretion by hydrogen sulfide.
Yuan P; Xue H; Zhou L; Qu L; Li C; Wang Z; Ni J; Yu C; Yao T; Huang Y; Wang R; Lu L
Nephrol Dial Transplant; 2011 Jul; 26(7):2119-26. PubMed ID: 21208996
[TBL] [Abstract][Full Text] [Related]
19. Effect of HMG CoA reductase inhibition on TGF-beta 1 mRNA expression in diabetic rat glomeruli.
Han DC; Kim JH; Cha MK; Song KI; Hwang SD; Lee HB
Kidney Int Suppl; 1995 Sep; 51():S61-5. PubMed ID: 7474692
[No Abstract] [Full Text] [Related]
20. Dickkopf-1 promotes hyperglycemia-induced accumulation of mesangial matrix and renal dysfunction.
Lin CL; Wang JY; Ko JY; Huang YT; Kuo YH; Wang FS
J Am Soc Nephrol; 2010 Jan; 21(1):124-35. PubMed ID: 20019166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
